ACM
PRTA icon

AlphaCrest Capital Management’s Prothena Corp PRTA Stock Holding History

AlphaCrest Capital Management’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,348
Closed -$561K – 1346
2022
Q1 		$561K Buy
+15,348
New +$553K 0.03% 844
2019
Q3 		– Sell
-14,200
Closed -$150K – 1321
2019
Q2 		$150K Buy
+14,200
New +$146K 0.01% 986

Other funds holding PRTA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AlphaCrest Capital Management's PRTA Position: Q2 2022 in Review

AlphaCrest Capital Management sold out of Prothena Corp (PRTA) in Q2 2022, closing a stake of 15,348 shares — an estimated $561K sold.

AlphaCrest Capital Management first reported a position in PRTA in Q2 2019 and held it in 2 quarters. The position peaked at $561K in Q1 2022. 166 funds tracked by Wall St. Rank hold PRTA as of Q2 2022.

  • AlphaCrest Capital Management reported no remaining Prothena Corp position as of Q2 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 15,348 Prothena Corp shares in Q2 2022, an estimated $561K.
  • AlphaCrest Capital Management first reported a position in Prothena Corp in Q2 2019 and held it in 2 quarters.
  • AlphaCrest Capital Management's Prothena Corp position peaked at $561K in Q1 2022.
  • 166 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2022.

Based on AlphaCrest Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.